Return to search

IPO Profile: Xenon Pharmaceuticals Inc

Company Details

Burnaby, BC


Description: Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications. It has an integrated platform, which includes in-house capabilities for human genetics, small molecule drug discovery, and preclinical and clinical development.

IPO Details

Exchange and Ticker: Nasdaq: XENE

Filing Range: 4.00 million shares @ $10.00 to $12.00

Offering Price: $9.00

Close price as of 11/5/14: $10.50

Offering Size: $36M

Shares Outstanding: 48.8M

Underwriters: Jefferies LLC, Wells Fargo Securities LLC

Co-manager: Canaccord Genuity

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Cooley LLP

Auditor: KPMG LLP

Market Capitalization on 11/28.14: $643.54M

Close price at current month end: $13.20

Investment Details

Venture Backers: Invesco Private Capital Inc, Fidelity Ventures, InterWest Partners LLC, Rbc Capital Partners, F Hoffmann La Roche AG, Takeda Ventures Inc, Growth Works Capital Ltd, Genome Canada, Genome Quebec, Novo A/S, Panorama Capital LLC, Five Corners Capital Inc, Pliant Corp, Pfizer Inc


  • 6/1/00 $9M
  • 4/5/01 $48M
  • 4/3/02 $6.9M
  • 4/11/06 $31M
  • 9/12/06 $5M
  • 12/7/06 $6M

Source: Thomson Reuters data